These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10811030)

  • 21. Design, synthesis and testing of amino-bicycloaryl based orally bioavailable thrombin inhibitors.
    Rewinkel JB; Lucas H; Smit MJ; Noach AB; van Dinther TG; Rood AM; Jenneboer AJ; van Boeckel CA
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2837-42. PubMed ID: 10522702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational design, synthesis, and X-ray structure of selective noncovalent thrombin inhibitors.
    Wagner J; Kallen J; Ehrhardt C; Evenou JP; Wagner D
    J Med Chem; 1998 Sep; 41(19):3664-74. PubMed ID: 9733491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors.
    Katz BA; Elrod K; Verner E; Mackman RL; Luong C; Shrader WD; Sendzik M; Spencer JR; Sprengeler PA; Kolesnikov A; Tai VW; Hui HC; Breitenbucher JG; Allen D; Janc JW
    J Mol Biol; 2003 May; 329(1):93-120. PubMed ID: 12742021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyanopeptide analogues: new lead structures for the design and synthesis of new thrombin inhibitors.
    Radau G; Stürzebecher J
    Pharmazie; 2002 Nov; 57(11):729-32. PubMed ID: 12611274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amide and alpha-keto carbonyl inhibitors of thrombin based on arginine and lysine: synthesis, stability and biological characterization.
    Brady SF; Sisko JT; Stauffer KJ; Colton CD; Qiu H; Lewis SD; Ng AS; Shafer JA; Bogusky MJ; Veber DF
    Bioorg Med Chem; 1995 Aug; 3(8):1063-78. PubMed ID: 7582980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potent thrombin inhibitors that probe the S1 subsite: tripeptide transition state analogues based on a heterocycle-activated carbonyl group.
    Costanzo MJ; Maryanoff BE; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Kauffman JA; Lewis JM; Krishnan R; Tulinsky A
    J Med Chem; 1996 Aug; 39(16):3039-43. PubMed ID: 8759623
    [No Abstract]   [Full Text] [Related]  

  • 27. Novel non-covalent azaphenylalanine thrombin inhibitors with an aminomethyl or amino group at the P1 position.
    Obreza A; Stegnar M; Urleb U
    Pharmazie; 2004 Sep; 59(9):659-67. PubMed ID: 15497744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
    Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
    J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bifunctional peptide boronate inhibitors of thrombin: crystallographic analysis of inhibition enhanced by linkage to an exosite 1 binding peptide.
    Skordalakes E; Elgendy S; Goodwin CA; Green D; Scully MF; Kakkar VV; Freyssinet JM; Dodson G; Deadman JJ
    Biochemistry; 1998 Oct; 37(41):14420-7. PubMed ID: 9772168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 position.
    Feng DM; Gardell SJ; Lewis SD; Bock MG; Chen Z; Freidinger RM; Naylor-Olsen AM; Ramjit HG; Woltmann R; Baskin EP; Lynch JJ; Lucas R; Shafer JA; Dancheck KB; Chen IW; Mao SS; Krueger JA; Hare TR; Mulichak AM; Vacca JP
    J Med Chem; 1997 Nov; 40(23):3726-33. PubMed ID: 9371237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
    Bhunia SS; Roy KK; Saxena AK
    J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and biological activity of novel rigid amidino-phenylalanine derivatives as inhibitors of thrombin.
    Mack H; Pfeiffer T; Hornberger W; Böhm HJ; Höffken HW
    J Enzyme Inhib; 1995; 9(1):73-86. PubMed ID: 8568568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity and crystallographic analysis of a new class of non-amide-based thrombin inhibitor.
    Lu T; Soll RM; Illig CR; Bone R; Murphy L; Spurlino J; Salemme FR; Tomczuk BE
    Bioorg Med Chem Lett; 2000 Jan; 10(1):79-82. PubMed ID: 10636249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
    Odake S; Kam CM; Powers JC
    J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of thrombin and other trypsin-like serine proteinases by cyclotheonamide A.
    Lewis SD; Ng AS; Baldwin JJ; Fusetani N; Naylor AM; Shafer JA
    Thromb Res; 1993 Apr; 70(2):173-90. PubMed ID: 8322286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel thrombin inhibitors incorporating weakly basic heterobicyclic P1-arginine mimetics: optimization via modification of P1 and P3 moieties.
    Kranjc A; Peterlin-Masic L; Ilas J; Prezelj A; Stegnar M; Kikelj D
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3251-6. PubMed ID: 15149685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Synthetic serine proteinase inhibitors. 6. Inhibition of trypsin, plasmin and thrombin by phenylpyruvic acids containing various basic groups].
    Markwardt F; Richter P; Stürzebecher J; Wagner G; Walsmann P
    Acta Biol Med Ger; 1974; 33(1):K1-7. PubMed ID: 4279020
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: thermodynamic and molecular modeling study.
    Menegatti E; Ferroni R; Nastruzzi C; Bortolotti F; Scalia S; Amiconi G; Bolognesi M; Coletta M; Onesti S; Fruttero R
    Farmaco; 1991 Nov; 46(11):1297-310. PubMed ID: 1811616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Crystallographic determination of the structures of human alpha-thrombin complexed with BMS-186282 and BMS-189090.
    Malley MF; Tabernero L; Chang CY; Ohringer SL; Roberts DG; Das J; Sack JS
    Protein Sci; 1996 Feb; 5(2):221-8. PubMed ID: 8745399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombin-like enzyme from Lachesis muta muta venom: isolation and topographical analysis of its active site structure by means of the binding of amidines and guanidines as competitive inhibitors.
    Magalhães A; Monteiro MR; Magalhães HP; Mares-Guia M; Rogana E
    Toxicon; 1997 Oct; 35(10):1549-59. PubMed ID: 9428102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.